Patient mortality and risk | DD-CKD | IDD-CKD | NDD-CKD | |||||
---|---|---|---|---|---|---|---|---|
Overall (n = 3,931) | Overall (n = 3,330) | Overall (n = 310,352) | Stage 3a (n = 222,651) | Stage 3b (n = 71,367) | Stage 4 (n = 15,033) | Stage 5 (n = 1,301) | ||
1Â year | Events, n | 857 | 845 | 8,298 | 4,338 | 2,766 | 1,069 | 125 |
Mortality risk, KM% (95% CI) | 22.47 (21.13–23.79) | 26.29 (24.74–27.80) | 2.79 (2.73–2.85) | 2.04 (1.98–2.10) | 4.03 (3.89–4.18) | 7.43 (7.00–7.85) | 10.21 (8.49–11.89) | |
2Â years | Events, n | 299 | 277 | 15,517 | 8,145 | 5,281 | 1,890 | 201 |
Mortality risk, KM% (95% CI) | 31.46 (29.93–32.96) | 36.44 (34.69–38.14) | 8.30 (8.20–8.40) | 6.08 (5.97–6.18) | 12.14 (11.89–12.38) | 21.32 (20.64–22.00) | 27.64 (25.03–30.16) | |
3Â years | Events, n | 218 | 186 | 13,964 | 7,661 | 4,663 | 1,501 | 139 |
Mortality risk, KM% (95% CI) | 38.97 (37.30–40.59) | 44.41 (42.53–46.23) | 13.69 (13.56–13.82) | 10.21 (10.08–10.35) | 19.84 (19.53–20.15) | 33.28 (32.47–34.08) | 40.79 (37.83–43.60) | |
5Â years | Events, n | 316 | 255 | 22,701 | 13,221 | 7,348 | 1,968 | 164 |
Mortality risk, KM% (95% CI) | 52.51 (50.62–54.32) | 58.36 (56.26–60.36) | 23.80 (23.63–23.96) | 18.50 (18.32–18.68) | 33.68 (33.29–34.06) | 51.18 (50.27–52.07) | 58.30 (55.14–61.23) |